The emerging arrival of the 40mg Tirzepatide dose represents a possibly groundbreaking advancement in the treatment of type 2 diabetes . This therapy builds upon the prior success of lower strengths , showing promising results in improving blood glucose readings and supporting a decrease in weight. Experts are assessing its overall effect on heart